Cargando…
Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007,...
Autores principales: | Lawson, Erin F., Wallace, Mark S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826634/ https://www.ncbi.nlm.nih.gov/pubmed/20425209 http://dx.doi.org/10.1007/s11916-009-0092-z |
Ejemplares similares
-
Current assessment practices for noncancer end points.
por: Shoaf, C R
Publicado: (1991) -
European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
por: Häuser, Winfried, et al.
Publicado: (2021) -
Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain
por: Nair, Abhijit S
Publicado: (2019) -
Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019) -
Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience
por: Chapman, C. Richard
Publicado: (2013)